LONG-TERM CONTROLLED TRIAL WITH DIPHOSPHONATE IN PATIENTS WITH OSTEOLYTIC BONE METASTASES
- 1 January 1983
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 321 (8317) , 146-149
- https://doi.org/10.1016/s0140-6736(83)92755-1
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Parenteral diphosphonates for treating malignant hypercalcemiaCancer, 1981
- EFFECT OF DICHLOROMETHYLENE DIPHOSPHONATE IN PAGET'S DISEASE OF BONE AND IN HYPERCALCÆMIA DUE TO PRIMARY HYPERPARATHYROIDISM OR MALIGNANT DISEASEThe Lancet, 1980
- Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases.Journal of Clinical Investigation, 1980
- Effects of Dichloromethylene Diphosphonate on Skeletal Mobilization of Calcium in Multiple MyelomaNew England Journal of Medicine, 1980
- INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979
- Calcium and cancerLife Sciences, 1978
- Mechanisms of bone destruction in the development of skeletal metastasesNature, 1976
- Evidence for the Secretion of an Osteoclast Stimulating Factor in MyelomaNew England Journal of Medicine, 1974
- Albumin standards and the measurement of serum albumin with bromcresol greenClinica Chimica Acta; International Journal of Clinical Chemistry, 1971
- Modifications of a specific assay for hydroxyproline in urineAnalytical Biochemistry, 1967